More than 27.85 million people have been reported to be infected by the novel coronavirus globally and 902,216 have died, according to a Reuters tally. Infections have been reported in more than 210 countries and territories since the first cases were identified in China in December 2019.
The country with the most coronavirus deaths is the United States with over 190,000 fatalities, followed by Brazil.
With billions of people around the world still suffering from the fallout of the crisis, a worldwide race for a vaccine is underway, with nine companies already in late-stage Phase 3 trials.
However clinical trials on one of the most advanced experimental Covid-19 vaccines, which is being developed by pharmaceutical company AstraZeneca and Oxford University, were "paused" this week after a volunteer developed an unexplained illness.
READ MORE
India reports record daily jump of 95,735 coronavirus cases
SEHA sets COVID-19 testing price at Dhs250 all across UAE
Tips to help kids adjust to masks, according to experts and parents
Russian trials 'too small'
Russia has already approved a vaccine and on Wednesday began inoculating volunteers in Moscow, the capital's deputy mayor said.
Russia announced last month that its vaccine, named "Sputnik V" — after the Soviet-era satellite that was the first launched into space in 1957 — had received approval.
Research published in The Lancet medical journal last week said patients involved in early tests in Russia developed antibodies with "no serious adverse events", although scientists cautioned the trials were too small.
Medical workers take care of patients suffering from the coronavirus disease. Reuters
High-profile Russians have already been vaccinated, including President Vladimir Putin's daughter, Moscow's mayor, and nationalist politician Vladimir Zhirinovsky.
Clinical trials of a Chinese-made vaccine in Brazil have shown "extremely positive" results, and a widespread vaccination campaign could begin as early as December, the governor of Sao Paulo state said.
AstraZeneca said it had "voluntarily paused vaccination to allow review of safety data", adding that in large-scale trials, illnesses will sometimes happen by chance, but must be reviewed independently.
Standard process
Britain's health minister Matt Hancock said it was not the first pause in the trials of the AstraZeneca vaccine.
"It's a standard process in clinical trials. There was a pause earlier in the summer and that was resolved without a problem," he told Sky News.
China, meanwhile, put its homegrown vaccines on display for the first time at a Beijing trade fair this week, and authorities hope one will be approved for use by the end of the year.
The economic impact of the virus continues to wreak havoc on economies around the world, with governments desperate to get back to normality.
Latin America and the Caribbean surpassed 300,000 virus deaths. Argentina's caseload surpassed the half-million mark, while in Peru, which has the highest per capita coronavirus death rate in the world, fatalities climbed beyond 30,000.
Agencies